Synergistic Bifurcation Treatment System

Publication ID: 24-11857442_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Bifurcation Treatment System,” Published Technical Disclosure No. 24-11857442_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857442_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,442.

Summary of the Inventive Concept

The present inventive concept integrates advanced technologies, such as AI, IoT, blockchain, and nanomaterials, with the patented stenting and treatment of bifurcated vessels to create a more powerful and effective system for treating bifurcations.

Background and Problem Solved

The original patent addresses the limitations of traditional stenting methods for treating bifurcated vessels. However, the new inventive concept recognizes that the original patent's approach can be further improved by incorporating synergistic combinations of distinct technologies. The new concept solves the problem of limited stent placement accuracy, inadequate real-time monitoring, and inefficient data transmission in traditional bifurcation treatment systems.

Detailed Description of the Inventive Concept

The Synergistic Bifurcation Treatment System comprises a stent delivery catheter integrated with an AI-powered imaging module for real-time visualization of vessel anatomy and optimal stent placement. The system also features a blockchain-secured, IoT-enabled stent delivery system that tracks and verifies stent deployment, ensuring secure data transmission to a healthcare network. Additionally, the system incorporates a biodegradable stent infused with micro-sensors for real-time monitoring of vessel health and stent performance, along with a data analytics module for predicting stent failure and optimizing treatment outcomes. The system can also be integrated with a robotic-assisted stent delivery catheter and a machine learning algorithm for predicting optimal stent placement and minimizing procedural complications. Furthermore, the system can utilize a nanomaterial-based stent coated with a therapeutic agent, which is designed to release the agent in a controlled manner, and the system tracks and verifies agent delivery and efficacy.

Novelty and Inventive Step

The new inventive concept's novelty lies in the synergistic combination of advanced technologies, such as AI, IoT, blockchain, and nanomaterials, with the patented stenting and treatment of bifurcated vessels. The inventive step is the integration of these distinct technologies to create a more powerful and effective system for treating bifurcations, which is not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the Synergistic Bifurcation Treatment System could include the use of different AI algorithms, varying IoT connectivity protocols, or alternative blockchain architectures. Variations could also include the integration of additional sensors or imaging modalities, such as ultrasound or optical coherence tomography, to further enhance the system's accuracy and effectiveness.

Potential Commercial Applications and Market

The Synergistic Bifurcation Treatment System has significant commercial potential in the medical device industry, particularly in the fields of interventional cardiology and vascular surgery. The system's ability to improve stent placement accuracy, reduce procedural complications, and enhance patient outcomes could lead to widespread adoption in hospitals and healthcare networks worldwide.

CPC Classifications

SectionClassGroup
A A61 A61F2/954
A A61 A61B90/39
A A61 A61F2/852
A A61 A61F2/856
A A61 A61F2/958
A A61 A61B2090/3966

Field of Art

Medical device engineering, specifically interventional cardiology and endovascular stent technologies, focusing on complex vessel treatment systems with expertise in catheter design, imaging integration, and minimally invasive medical procedures

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or interventional cardiologist with advanced technical training, familiar with medical device innovation, stent deployment techniques, and emerging digital health technologies, possessing knowledge of medical imaging, sensor integration, and advanced materials

Obviousness Rationale

A PHOSITA would recognize that the PTD's technological extensions represent predictable combinations of known medical device technologies, where the integration of AI, IoT, and nanomaterials into stent delivery systems represents incremental improvements rather than non-obvious innovations. The fundamental stent deployment methodology remains consistent with the source patent, while the proposed technological enhancements represent logical evolutionary steps in medical device design. These variations would be considered obvious modifications that leverage existing technological capabilities within the medical device engineering domain.

Obvious Combinations & Variations

Source Patent Element
Stent delivery method for bifurcated vessels using multiple catheters
PTD Variation
AI-powered imaging module integrated with stent delivery catheter for real-time visualization
Obviousness Reasoning
Combining medical imaging technologies with stent delivery is a known technique, representing a predictable application of existing diagnostic imaging capabilities to improve procedural accuracy
Source Patent Element
Guidewire-based stent positioning method
PTD Variation
Robotic-assisted stent delivery catheter with machine learning placement optimization
Obviousness Reasoning
Enhancing guidewire-based positioning with robotic and algorithmic technologies represents a logical extension of existing precision placement techniques
Source Patent Element
Stent deployment in bifurcated vessels
PTD Variation
Blockchain-secured, IoT-enabled stent tracking and verification system
Obviousness Reasoning
Implementing digital tracking and verification for medical device deployment is an obvious technological progression using standard communication and security protocols
Source Patent Element
Implantable stent scaffold design
PTD Variation
Biodegradable stent with integrated micro-sensors for real-time vessel health monitoring
Obviousness Reasoning
Incorporating sensor technologies into implantable medical devices represents a predictable innovation within materials science and medical device engineering
Source Patent Element
Stent as a medical intervention platform
PTD Variation
Nanomaterial-based stent with controlled therapeutic agent release mechanism
Obviousness Reasoning
Developing advanced material technologies for targeted drug delivery is a well-established approach in biomedical engineering with known methodological frameworks
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857442 and the disclosed technological variations, a person having ordinary skill in the art would find the proposed bifurcation treatment system variations obvious and lacking non-obvious inventive merit. The incremental technological enhancements represent predictable combinations of known medical device design principles, digital health technologies, and materials science techniques, thereby rendering potential patent claims obvious and anticipatable under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,442
TitleSystem and methods for treating a bifurcation
Assignee(s)Advanced Bifurcation Systems Inc.